Key result
Levosimendan administration reduced mortality and shortened ICU stays compared to conventional inotropic agents in patients with left ventricular dysfunction post CABG.
Why the study?
The study aimed to determine the effect of levosimendan compared to conventional inotropic agents on outcomes in patients with LV dysfunction undergoing CABG.
Does intravenous levosimendan improve postoperative outcomes and reduce mortality in patients with LV dysfunction undergoing CABG compared to conventional inotropic agents?
Observational (n=100)
No
Does intravenous levosimendan improve postoperative outcomes and reduce mortality in patients with LV dysfunction undergoing CABG compared to conventional inotropic agents?
In patients with severe LV dysfunction undergoing CABG, prophylactic levosimendan administration is associated with significantly reduced mortality and shorter ICU stays compared to conventional inotropic support.
Answers are grounded in this paper and cite their sources.
Levosimendan was associated with reduced mortality and shorter ICU stay post-CABG; observational data leaves open need for confirmatory RCTs.
BACKGROUND: Coronary artery bypass graft (CABG) surgery is the standard of care for the management of patients with three-vessel and left main coronary artery disease (CAD) with viable myocardium. Positive inotropic agents are the treatment of choice in patients with LV dysfunction post CABG. Levosimendan is an inotropic drug that has three major mechanisms of action: positive inotropy, vasodilation, and cardiac cytoprotection. Levosimendan is a calcium sensitizer, it improves myocardial contractility by sensitising troponin C to calcium without increasing myocardial oxygen consumption and without impairing relaxation and diastolic function. AIM: The aim of this study was to determine the effect of levosimendan compared to the conventional inotropic agents on the outcomes of patients with LV dysfunction undergoing CABG. METHODS: It is a prospective observational study that patients were divided into 2 groups of 50 patients each. Group A received intravenous levosimendan (at a dose of 0.2μg per kilogram of body weight per minute for 1 hour, followed by a dose of 0.1μg per kilogram per minute for 23 hours), with the infusion started at the induction of anesthesia while Group B which included patients who received conventional drugs. Clinical examination, Hemodynamic data and Laboratory investigations pre-operative and post-operative were collected.
No takes yet. Share an insight, caveat, or question.
Hussein et al. (2022) conducted an observational in Left ventricular dysfunction post coronary artery bypass graft (CABG) surgery (n=100). Levosimendan vs. Conventional inotropic and vasopressor treatment was evaluated on Mortality (RR 0.41, 95% CI 0.21 - 0.79, p=0.004). Levosimendan administration reduced mortality and shortened ICU stays compared to conventional inotropic agents in patients with left ventricular dysfunction post CABG.
Synapse has enriched 10 related papers. Consider them for comparative context: